Nivolumab Injectable Product Clinical Trials
3 recruitingDrug
Phase 12Phase 21
Showing 1–3 of 3 trials
Recruiting
Phase 2
Combination of TATE and PD-1 Inhibitor in Liver Cancer
Gastric CancerHepatocellular Carcinoma
Teclison Ltd.54 enrolled3 locationsNCT03259867
Recruiting
Phase 1
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
Soft Tissue SarcomaSarcomaOsteosarcoma+5 more
Baylor College of Medicine25 enrolled1 locationNCT04995003
Recruiting
Phase 1
A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Pancreatic CancerPancreatic Ductal Adenocarcinoma
University of Rochester20 enrolled1 locationNCT04477343